Subnavigation

• Influenza
• Surveillance and monitoring
  • Updates
  • FluID
• GISRS and laboratory
  • FluNet
  • National Influenza Centres
  • WHO Collaborating Centres for influenza and Essential Regulatory Laboratories
  • WHO H5 Reference Laboratories
  • Antiviral susceptibility surveillance
  • WHO External Quality Assessment Project
  • Shipping and logistic activities
• PIP Framework
  • Advisory Group
  • Virus Sharing
  • Benefit Sharing
• Vaccines
  • Vaccine viruses
  • Vaccine use
• Patient care
  • Clinical management
  • Antivirals
• Human animal interface
  • Avian influenza in humans
  • Swine influenza in humans
• Public health preparedness
• Information resources
  • Research
  • Training
  • Publications

Avian influenza

Not all avian influenza viruses cause disease in humans. However, some can infect humans and cause severe disease. The most well known of these are avian influenza H5N1 viruses which circulate in poultry.

• Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines
• WHO guidelines for investigation of human cases of avian influenza A(H5N1)
• Recommendations and laboratory procedures for detection of avian influenza A(H5N1) virus in specimens from suspected human cases
  Revised August 2007
• Responding to the avian influenza pandemic threat
  Recommended strategic actions
• Avian Influenza H5N1 at the human-animal interface: Update on selected projects
• Availability of a new recombinant A(H5N1) vaccine virus
  14 July 2010
• Availability of a new recombinant H5N1 vaccine virus
  June 2010
• Current WHO phase of pandemic alert (avian influenza H5N1)
• The FAO-OIE-WHO Collaboration: Tripartite Concept Note
  Sharing responsibilities and coordinating global activities to address health risks at the animal-human-ecosystems interfaces
• Protection of individuals with high poultry contact in areas affected by avian influenza H5N1: Consolidation of pre-existing guidance
  February 2008
• A summary of tracking avian influenza A(H5N1) specimens and viruses shared with WHO from 2003 to 2007
  31 January 2008
• WHO accepts positive PCR test results of H5 infection in humans from the following laboratories
  May 2011
• Clinical management of human infection with avian influenza A (H5N1) virus
  15 August 2007
• Summary of the second WHO consultation on clinical aspects of human infection with avian influenza A(H5N1) virus
• WHO case definitions for human infections with influenza A(H5N1) virus
  29 August 2006
• WHO procedures for obtaining release of H5N1 sequences to the public domain
  23 August 2006
• WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus
  May 2006
• Food safety issues
  November 2005
• WHO Working Group on Influenza Research at the Human/Animal Interface
  Activities of this group are now the responsibility of the OFFLU/WHO collaboration
  November 2005
• WHO guidance on public health measures in countries experiencing their first outbreaks of H5N1 avian influenza
  October 2005
• Avian influenza: assessing the pandemic threat
• WHO guidelines for the storage and transport of human and animal specimens for laboratory diagnosis of suspected avian influenza A infection
  June 2009
• WHO laboratory biosafety guidelines for handling specimens suspected of containing avian influenza A virus
  12 January 2005
• Advice for people living in areas affected by bird flu or avian influenza
  8 November 2004
• H5N1 avian influenza: a chronology of key events
  12 February 2004
• Preliminary clinical and epidemiological description of influenza A (H5N1) in Viet Nam
  12 February 2004
• WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection
  12 January 2005
• Guidelines for the use of seasonal influenza vaccine in humans at risk of H5N1 infection
  30 January 2004